ФИТОТЕРАПИЯ ПРИ ВОСПАЛИТЕЛЬНЫХ ЗАБОЛЕВАНИЯХ ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫ

В статье обсуждается эффективность фитотерапии при воспалительных заболеваниях предстательной железы. В данном обзоре литературы приведены клинические исследования успешного использования растительных компонентов в лечении и профилактике хронического простатита и купировании симптомов нижних мочевыводящих путей (СНМП). Биологические активные вещества корня крапивы, семян тыквы, пальмы сабаль и цинка весьма эффективны в терапии хронического простатита за счет противовоспалительного, антипролиферативного, антиандрогенного и антиоксидантного действий. Фитопрепараты, содержащие эти вещества, могут быть рекомендованы в качестве первой линии коррекции СНМП при хроническом простите категорий III и IV; в качестве общеукрепляющего средства для мужчин, ведущих малоподвижный образ жизни в возрасте старше 35 лет.

1. Pirola GM, Verdacchi T, Rosadi S, Annino F, De Angelis M. Chronic prostatitis: current treatment options. Res Rep Urol. 2019 Jun 4;11:165–174. DOI: 10.2147/RRU.S194679

2. Clemens JQ, Meenan RT, O’Keeffe Rosetti MC, Kimes T, Calhoun EA. Prevalence of and risk factors for prostatitis: population based assessment using physician assigned diagnoses. J Urol. 2007 Oct;178 (4 Pt 1):1333–7. DOI: 10.1016/j.juro.2007.05.140

3. Nickel JC. Prostatitis. Canadian Urological Association Journal. 2011;5 (5):306–5. DOI: 10.5489/cuaj.11211

4. Pontari MA, Joyce GF, Wise M, McNaughton-Collins M. Urologic Diseases in America Project. Prostatitis. J Urol. 2007 Jun;177 (6):2050–7. DOI: 10.1016/j.juro.2007.01.128

5. Аполихин О. И., Комарова В. А., Никушина А .А., Сивков А. В. Болезни предстательной железы в Российской Федерации: статистические данные 2008–2017 гг. Экспериментальная и клиническая урология. 2019;2:4–13. DOI: 10.29188/2222–8543–2019–11–2-4–12

6. Krieger JN, Nyberg L Jr, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA. 1999 Jul 21;282 (3):236–7. DOI: 10.1001/jama.282.3.236

7. Виноградов И.В., Живулько А.Р., Короле в С.В. Хронический простатит, патогенетические механизмы влияния на мужскую фертильность. Вестник последипломного медицинского образования. 2018;4:48–54

8. Stamatiou K, Pierris N. Serenoa repens extract additionally to quinolones in the treatment of chronic bacterial prostatitis. The preliminary results of a long term observational study. Arch Ital Urol Androl. 2013 Dec 31;85 (4):190–6. DOI: 10.4081/aiua.2013.4.190

9. Wagenlehner FM, van Till JW, Magri V, Perletti G, Houbiers JG, Weidner W, Nickel JC. National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) symptom evaluation in multinational cohorts of patients with chronic prostatitis/chronic pelvic pain syndrome. Eur Urol. 2013 May;63 (5):953–9. DOI: 10.1016/j.eururo.2012.10.042

10. Капр ин А.Д., Кос тин А.А., П опов С.В. Медикаментозная терапия хронического простатита. Русский медицинский журнал. Медицинское обозрение. 2015;23 (17):1010–2

11. Weidner W. Treating chronic prostatitis: antibiotics no, alpha-blockers maybe. Ann Intern Med. 2004 Oct 19;141 (8):639–40. DOI: 10.7326/0003–4819–141-8–200410190–00012

12. Попов С.В. , Мазо Е.Б. Этиотропная терапия хронического бактериального простатита. Урология. 2008;3:36–41

13. Cunha BA, Gran A, Raza M. Persistent extended-spectrum β-lactamase-positive Escherichia coli chronic prostatitis successfully treated with a combination of fosfomycin and doxycycline. Int J Antimicrob Agents. 2015 Apr;45 (4):427–9. DOI: 10.1016/j. ijantimicag.2014.12.019

14. Magri V, Boltri M, Cai T, Colombo R, Cuzzocrea S, De Visschere P, et al. Multidisciplinary approach to prostatitis. Arch Ital Urol Androl. 2019 Jan 18;90 (4):227–248. DOI: 10.4081/aiua.2018.4.227

15. Engelmann U, Walther C, Bondarenko B, Funk P, Schlafke S. Efficacy and safety of a combination of sabal and urtica extract in lower urinary tract symptoms. A randomized, double-blind study versus tamsulosin. Arzneimittelforschung. 2006;56 (3):222–9. DOI: 10.1055/s-0031–1296714

16. Hu M, Wazir J, Ullah R, Wang W, Cui X, Tang M, Zhou X. Phytotherapy and physical therapy in the management of chronic prostatitis-chronic pelvic pain syndrome. Int Urol Nephrol. 2019 Jul;51 (7):1081–1088. doi: 10.1007/s11255–019–02161-x

17. Saavedra MJ, Aires A, Dias C, Almeida JA, De Vasconcelos MC, Santos P, Rosa EA. Evaluation of the potential of squash pumpkin by-products (seeds and shell) as sources of antioxidant and bioactive compounds. J Food Sci Technol. 2015 Feb;52 (2):1008–15. DOI: 10.1007/s13197–013–1089–5

18. Safarinejad MR. Urtica dioica for treatment of benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled, crossover study. J Herb Pharmacother. 2005;5 (4):1–11

19. De Monte C, Carradori S, Granese A, Di Pierro GB, Leonardo C, De Nunzio C. Modern extraction techniques and their impact on the pharmacological profile of Serenoa repens extracts for the treatment of lower urinary tract symptoms. BMC Urol. 2014 Aug 11;14:63. DOI: 10.1186/1471–2490–14–63

20. Damiano R, Cai T, Fornara P, Franzese CA, Leonardi R, Mirone V. The role of Cucurbita pepo in the management of patients affected by lower urinary tract symptoms due to benign prostatic hyperplasia: A narrative review. Arch Ital Urol Androl. 2016 Jul 4;88 (2):136–43. DOI: 10.4081/aiua.2016.2.136

21. Chrubasik JE, Roufogalis BD, Wagner H. A comprehensive review on the stinging nettle effect and efficacy profiles Part II: Urtica radix. Phytomedicine. 2007 Aug;14 (7–8):568–79. DOI:10.1016/j.phymed.2007.03.014

22. Кульченко Н.Г. Оптимизация подходов консервативной терапии доброкачественной гиперплазии предстательной железы ингибиторами 5-альфаредуктазы. Клинико-морфологическое исследование. Курский научно-практический вестник «Человек и его здоровье». 2012;1:101–6

23. Yang J, Te AE. Saw palmetto and finasteride in the treatment of category-III prostatitis/chronic pelvic pain syndrome. Curr Urol Rep. 2005 Jul;6 (4):290–5

24. Gordon AE, Shaughnessy AF. Saw palmetto for prostate disorders. Am Fam Physician. 2003 Mar 15;67 (6):1281–3

25. Colado-Velázquez J, Mailloux-Salinas P, Medina-Contreras JML, Cruz-Robles D, Bravo G. Effect of Serenoa repens on oxidative stress, inflammatory and growth factors in obese wistar rats with benign prostatic hyperplasia. Phytother Res. 2015 Oct;29 (10):1525–31. DOI: 10.1002/ptr.5406

26. Penugonda K, Lindshield B. Fatty acid and phytosterol content of commercial saw palmetto supplements. Nutrients. 2013 Sep 13;5 (9):3617–33. DOI: 10.3390/nu5093617

27. Procida G, Stancher B, Cateni F, Zacchigna M. Chemical composition and functional characterisation of commercial pumpkin seed oil. J Sci Food Agric. 2013 Mar 30;93 (5):1035–41. DOI: 10.1002/jsfa.5843

28. Tantawy SA, Elgohary HM, Kamel DM. Trans-perineal pumpkin seed oil phonophoresis as an adjunctive treatment for chronic nonbacterial prostatitis. Res Rep Urol. 2018 Sep 18;10:95–101. DOI: 10.2147/RRU.S167896

29. Hong H, Kim CS, Maeng S. Effects of pumpkin seed oil and saw palmetto oil in Korean men with symptomatic benign prostatic hyperplasia. Nutr Res Pract. 2009 Winter;3 (4):323–7. DOI: 10.4162/nrp.2009.3.4.323

30. Guan Q, Zheng Y, Wei X, Wang S, Su B, Yu S. The Effect of Flavonoids on Chronic Prostatitis: A Meta-analysis of Published Randomized Controlled Trials. J Natl Med Assoc. 2019 May 23. pii: S0027–9684 (19)30011–2. DOI: 10.1016/j.jnma.2019.04.007

31. Schilcher H, Dunzendorfer U, Ascali F. D7-Sterols: the prostatotropic principle of pumpkin seeds. Urologe B. 1987;27:316–319

32. Abdel-Rahman MK. Effect of pumpkin seed (Cucurbita pepo L) diets on benign prostatic hyperplasia (BPH): chemical and morphometric evaluation in rats. World J Chem. 2006;1 (1):33–40

33. Moradi HR, Erfani Majd N, Esmaeilzadeh S, Fatemi Tabatabaei SR. The histological and histometrical effects of Urtica dioica extract on rat’s prostate hyperplasia. Vet Res Forum. 2015 Winter;6 (1):23–9

34. Pigat N, Reyes-Gomez E, Boutillon F, Palea S, Barry Delongchamps N, Koch E, Goffin V. Combined Sabal and Urtica Extracts (WS® 1541) Exert Anti-proliferative and Anti-inflammatory Effects in a Mouse Model of Benign Prostate Hyperplasia. Front Pharmacol. 2019 Mar 29;10:311. DOI: 10.3389/fphar.2019.00311

35. Dhouibi R, Affes H, Ben Salem M, Hammami S, Sahnoun Z, Zeghal KM, Ksouda K. Screening of pharmacological uses of Urtica dioica and others benefits. Prog Biophys Mol Biol. 2019 Jun 1. pii: S0079–6107 (19)30098–7. DOI: 10.1016/j.pbiomolbio.2019.05.008

36. Cheetham PJ. Role of complimentary therapy for male LUTS. Curr Urol Rep. 2013 Dec;14 (6):606–13. DOI: 10.1007/s11934–013–0372–3

37. Powell SR. The antioxidant properties of zinc. J Nutr. 2000May;130(5S Suppl):1447S-54S. DOI: 10.1093/jn/130.5.1447S

38. Costello LC, Franklin RB. A comprehensive review of the role of zinc in normal prostate function and metabolism; and its implications in prostate cancer. Arch Biochem Biophys. 2016 Dec 1;611:100–112. DOI: 10.1016/j.abb.2016.04.014

39. Flynn A, Hirvonen T, Mensink GB, Ocké MC, Serra-Majem L, Stos K, et al. Intake of selected nutrients from foods, from fortifi-cation and from supplements in various European countries. Food Nutr Res. 2009 Nov 12;53. DOI: 10.3402/fnr.v53i0.2038

40. Cui D, Han G, Shang Y, Mu L, Long Q, Du Y. The effect of chronic prostatitis on zinc concentration of prostatic fluid and seminal plasma: a systematic review and meta-analysis. Curr Med Res Opin. 2015;31 (9):1763–9. DOI: 10.1185/03007995.2015.1072707

41. Goodarzi D, Cyrus A, Baghinia MR, Kazemifar AM, Shirincar M. The efficacy of zinc for treatment of chronic prostatitis. Acta Med Indones. 2013 Oct;45 (4):259–64